Oncopeptides has a number of policy documents and manuals containing rules and recommendations providing guidance in the Company’s business operations and for its employee’s Internal policy documents include the rules of procedure for the board of directors, instructions for the CEO and instructions for financial reporting.
Oncopeptides’ corporate governance has, prior to the listing on Nasdaq Stockholm, been governed by the Swedish Companies Act (Sw. aktiebolagslagen (2005:551)), the Swedish Annual Accounts Act (Sw. årsredovisningslagen (1995:1554)) and other applicable laws and regulations, the Company’s articles of association and internal policy documents.
After the general meeting, the board of directors is the Company’s highest decision-making body. The board of directors shall be responsible for the organization and management of the Company’s affairs.